Tech & Research-Based Innovations
A8 is a strategic R&D actor and business champion that specialises in commercialising research-based innovations.
In particular, we focus on technologies born and developed in European Research Council (ERC), European Innovation Council (EIC) and European Institute of Innovation & Technology (EIT) funded research.
We work mostly within the life sciences and engineering domains, with deep tech as a technological focus area. Above all, we are interested in working with innovators that can contribute to develop sustainable & green solutions.
The European Commission and Sofia Angels Ventures are organising a workshop all about the EU’s Digital Markets Act (DMA) – a landmark legislation set to reshape the digital landscape.
The workshop will be running from 1pm to 4pm (EET) on February 20th at Sofia’s House of Europe.
Polish BioTech startup SeaSoil was crowned the Ventures Thrive cohort 1 winner at the VT Demo Day, held on 26th January 2024. The startup was represented by CEO Michael Cyrankiewicz, who pitched his way to success and secured €15k in prize money.
SeaSoil is fighting plastic pollution by transforming agricultural waste into a biomaterial similar to popular plastics.
The SeaSoil team creates this innovative material by putting agricultural and food waste through a biotechnologically advanced process which, in turn, produces new molecules similar to popular plastics, such as polypropylene and polyethylene. This material is also biodegradable in all conditions of microbial contamination (e.g. sea, soil, and forests), meaning that at the end of its life it will leave behind compost and other micronutrients commonly present in the environment.
These benefits, together with the material’s waterproof, impact-resistant, and durable nature, make SeaSoil’s product an ideal replacement for plastic in agriculture (as well as other industries).
Are you an academic researcher looking to enhance your entrepreneurial skills, market knowledge and industry connections, allowing you to take your new technology to the market? OR
A constantly innovating enterprise wanting to incorporate new ideas from the academic world into your offering?
Venture Alliances offers a residency program through which academic professionals and enterprises get to work together hands-on, combining the theoretical expertise of the researchers with the practical knowledge, skills and attitudes of the experienced entrepreneur. The end goal of the program is the creation of new joint ventures or joint R&D projects.
SynergistEIC’s latest initiative is looking to support 15 startups (5 EIC applicants and 10 non-EIC applicants) through a comprehensive six-month programme and €750k in funding.
1 | Up to €50k in grant funding
2 | Expert advice on business development
3 | An acceleration programme to increase your scalability
4 | Workshops tackling EU funding and procurement
5 | Opportunities to network with ecosystem players
Antti Heikkilä
We can work with you to prepare the proposal. We also partner with eligible ERC PoC projects to identify the use case and mature the business idea. In EIC Transition projects, we can join the consortium and take on the role of ‘business champion’ to elevate technology, business and funding readiness, while managing communication & dissemination requirements.
A8 and the Weizmann Institute of Science have received European Innovation Council funding to demonstrate an innovative, safe and cost-effective cancer radiotherapy approach based on electrons at high energies. Prof. Victor Malka’s team at the Department of Physics of Complex Systems have found a way to routinely generate focused, highly energetic electron beams by compact laser plasma accelerators in the ideal energy range for the treatment of tumours located deep within the body (such as prostate or lung cancer).
The final aim is to create a compact and affordable radiotherapy instrument, with lower irradiation effects on the adjacent healthy tissues and organs. A8 has been tasked with managing the commercialisation of the technology. During the coming years, we will work towards demonstrating commercial feasibility, enhancing acceptance among key stakeholders and improving investment readiness.
Roots in a demanding research environment
Antti, our CEO, started his journey at CERN in Geneva, where his mission was to get industry to attend to the R&D efforts of the Large Hadron Collider. He suddenly realized that in such a multicultural environment, one needs to build externally funded projects in order to enable intersectoral development efforts whilst avoiding political conflicts. This eventually led to the establishment of a number of challenging multi-million euro projects with partners in a number of countries, representing research organisations, universities, SMEs and large corporations.
Addressing ‘no ownership’ challenge in tech transfer
Being entrepreneurial minded, Antti aspired to achieve more out of these one-off projects. Then, Tuomo came along, and after a while, the two of them understood the real gap in the commercialisation of disruptive innovations in Europe – All the current players wanted to play on their own turf without any real risk taking capacity. The solution? A strong multi-skilled external team supporting researchers wanting to commercialise their innovations. Also, they quickly figured out that money is not a major motivator for any one of the stakeholders involved. They then recognised that there is a need to fix these shortcomings and create a venture builder that does not count on having the researcher trained as an entrepreneur, and facilitates direct market access through real-life pilots and R&D collaborations.
It’s a long journey, but we’re getting there
Now, years later, we have worked with over a hundred researchers, gaining expertise on all the steps involved in the long journey towards market introduction, growth and exits. Finally, we have arrived at a phase where we have started a more sustainable effort aiming at serving tens of cases yearly and creating 100-200 companies during the next ten years.
Have an inquiry or some feedback for us? Fill out this form to contact our team.